Alerts will be sent to your verified email
Verify Email
ZIMLAB
|
Zim Laboratories
|
Jagsonpal Pharma
|
Bharat Parenterals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
11.2 % | n/a | 0.41 % |
|
Financials
|
|||
|
5 yr Average ROE
|
6.88 % | 11.8 % | 12.73 % |
|
5yr average Equity Multiplier
|
1.92 | 1.31 | 1.76 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 1.18 | 0.86 |
|
5yr Avg Net Profit Margin
|
3.75 % | 7.67 % | 8.73 % |
|
Price to Book
|
2.21 | 4.74 | 5.09 |
|
P/E
|
30.58 | 39.53 | 69.21 |
|
5yr Avg Cash Conversion Cycle
|
35.7 Days | -6.79 Days | 122.06 Days |
|
Inventory Days
|
67.21 Days | 60.26 Days | 46.56 Days |
|
Days Receivable
|
97.06 Days | 25.87 Days | 179.99 Days |
|
Days Payable
|
149.76 Days | 67.96 Days | 95.97 Days |
|
5yr Average Interest Coverage Ratio
|
3.65 | 51.15 | 22.68 |
|
5yr Avg ROCE
|
13.04 % | 15.71 % | 16.02 % |
|
5yr Avg Operating Profit Margin
|
12.88 % | 11.17 % | 15.57 % |
|
5 yr average Debt to Equity
|
0.42 | 0.03 | 0.26 |
|
5yr CAGR Net Profit
|
39.21 % | 29.92 % | -9.67 % |
|
5yr Average Return on Assets
|
3.71 % | 9.04 % | 8.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
33.26 % | 68.09 % | 73.27 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.25 % | -1.15 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zim Laboratories
|
Jagsonpal Pharma
|
Bharat Parenterals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Capex
|
Capex
|
-
|
-
|
|
Customer Segment
|
Customer Segment
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|